This analysis, performed on transcriptomic data of 468 patients, showed that altered expressions of AKR1C1, AKR1C2, SLC7A5, NMI, PLAU, TBC1D2, TGM2, and WIZ correlated with poor survival of ccRCC patients. Here, NMI is linked to nonpapillary renal cell carcinoma.